{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:41:38Z","timestamp":1789879298795,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.lfs.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T02:34:04Z","timestamp":1543890844000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3653-8035","authenticated-orcid":false,"given":"Larissa Akemi","family":"Kido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"de Almeida Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"M\u00e1rio Roberto","family":"Mar\u00f3stica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria Helena Alves","family":"Cagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.12.002_bb0005","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1158\/0008-5472.CAN-04-2840","article-title":"Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer","volume":"64","author":"Adhami","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.03.029","article-title":"IKKalpha at the crossroads of inflammation and metastasis","volume":"129","author":"Affara","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tice.2017.12.008","article-title":"Nintedanib effects on delaying cancer progression and decreasing COX-2 and IL-17 in the prostate anterior lobe in TRAMP mice","volume":"50","author":"Alves","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0020","first-page":"4792","article-title":"Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer","volume":"9","author":"Ayala","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0092-8674(02)00622-0","article-title":"Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models","volume":"108","author":"Balmain","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0030","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0192623314531351","article-title":"Extra-prostatic transgene-associated neoplastic lesions in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice","volume":"43","author":"Berman-Booty","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0040","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1158\/1078-0432.CCR-07-4905","article-title":"Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells","volume":"14","author":"Bianco","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-10-258","article-title":"Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4","volume":"10","author":"Cervi","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0050","first-page":"3181","article-title":"Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer","volume":"7","author":"Chi","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.002_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2353\/ajpath.2008.070602","article-title":"Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer","volume":"172","author":"Chiaverotti","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2004.08.002","article-title":"The role of the stromal microenvironment in prostate cancer","volume":"15","author":"Condon","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1071\/RD01010","article-title":"Estrogenic effects on prostatic differentiation and carcinogenesis","volume":"13","author":"Cunha","year":"2001","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.lfs.2018.12.002_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tice.2016.03.005","article-title":"Morphology and MMP-9, AR and IGFR-1 responses of the seminal vesicle in TRAMP mice model","volume":"48","author":"Dal Pozzo","year":"2016","journal-title":"Tissue Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0080","first-page":"3","article-title":"Molecular pathology of cyclooxygenase-2 in neoplasia","volume":"30","author":"Fosslien","year":"2000","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.lfs.2018.12.002_bb0085","first-page":"325","article-title":"Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.lfs.2018.12.002_bb0090","first-page":"3325","article-title":"Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model","volume":"57","author":"Foster","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.pcan.4500296","article-title":"Pathologic progression of autochthonous prostate cancer in the TRAMP model","volume":"2","author":"Gingrich","year":"1999","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.lfs.2018.12.002_bb0100","first-page":"4096","article-title":"Metastatic prostate cancer in a transgenic mouse","volume":"56","author":"Gingrich","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/019262339602400414","article-title":"A transgenic mouse prostate cancer model","volume":"24","author":"Gingrich","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10555-013-9487-8","article-title":"Mouse models of prostate cancer: picking the best model for the question","volume":"33","author":"Grabowska","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lfs.2018.12.002_bb0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.pcan.4500422","article-title":"Androgens and growth factors in prostate cancer: a transgenic perspective","volume":"3","author":"Greenberg","year":"2000","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.lfs.2018.12.002_bb0120","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2018.12.002_bb0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/modpathol.3800052","article-title":"Unusual subtypes of prostate cancer","volume":"17","author":"Grignon","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-12-2704","article-title":"Tissue damage-associated \u201cdanger signals\u201d influence T-cell responses that promote the progression of preneoplasia to cancer","volume":"73","author":"He","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0135","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s11255-016-1341-9","article-title":"A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice","volume":"48","author":"Hu","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0140","first-page":"2736","article-title":"Angiogenesis and prostate cancer: identification of a molecular progression switch","volume":"61","author":"Huss","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0145","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1158\/0008-5472.CAN-08-0107","article-title":"The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth","volume":"68","author":"Jin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pros.10215","article-title":"Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model","volume":"55","author":"Kaplan-Lefko","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2018.12.002_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"i-xv","key":"10.1016\/j.lfs.2018.12.002_bb0160","article-title":"Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer","volume":"78","author":"Kasper","year":"1998","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2018.12.002_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/ERC-15-0540","article-title":"Anti-inflammatory therapies in TRAMP mice: delay in PCa progression","volume":"23","author":"Kido","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mrfmmm.2005.02.012","article-title":"The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research","volume":"576","author":"Klein","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0175","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/onc.2010.367","article-title":"Up for mischief? IL-17\/Th17 in the tumor microenvironment","volume":"29","author":"Maniati","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.12.002_bb0180","first-page":"2239","article-title":"A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential","volume":"61","author":"Masumori","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0185","doi-asserted-by":"crossref","first-page":"93867","DOI":"10.18632\/oncotarget.21305","article-title":"The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model","volume":"8","author":"Melis","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2018.12.002_bb0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/pros.22934","article-title":"Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model","volume":"75","author":"Montico","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2018.12.002_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00418-014-1193-2","article-title":"Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice","volume":"142","author":"Montico","year":"2014","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0200","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/pros.23045","article-title":"Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences","volume":"75","author":"Montico","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2018.12.002_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neo.2017.04.005","article-title":"Withaferin A inhibits prostate carcinogenesis in a PTEN-deficient mouse model of prostate cancer","volume":"19","author":"Moselhy","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.lfs.2018.12.002_bb0210","first-page":"92","article-title":"Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting","volume":"2","author":"Nandana","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0215","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1158\/1078-0432.CCR-04-0732","article-title":"Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model","volume":"10","author":"Narayanan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0220","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1073\/pnas.0804701105","article-title":"Targeting the stromal androgen receptor in primary prostate tumors at earlier stages","volume":"105","author":"Niu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2018.12.002_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/cbin.10881","article-title":"Nintedanib treatment delays prostate dorsolateral lobe cancer progression in the TRAMP model: contribution to the epithelial-stromal interaction balance","volume":"42","author":"Nogueira-Pangrazi","year":"2018","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2018.12.002_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pros.20692","article-title":"The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine lady transgenic prostate","volume":"68","author":"Palmer","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2018.12.002_bb0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molonc.2013.02.005","article-title":"Genetically engineered mouse models of prostate cancer","volume":"7","author":"Parisotto","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0240","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.18632\/oncotarget.4380","article-title":"Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions","volume":"6","author":"Pedrosa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2018.12.002_bb0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/carcin\/bgp052","article-title":"Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer","volume":"30","author":"Persano","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2018.12.002_bb0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jnci\/djr029","article-title":"Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer","volume":"103","author":"Powolny","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2018.12.002_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3816\/CGC.2005.n.034","article-title":"Cyclooxygenase-2: a therapeutic target for prostate cancer","volume":"4","author":"Pruthi","year":"2005","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0260","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1158\/0008-5472.CAN-09-0758","article-title":"Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model","volume":"69","author":"Pu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0265","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1158\/0008-5472.CAN-08-1332","article-title":"Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model","volume":"68","author":"Raina","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0270","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0275","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s11095-011-0625-0","article-title":"Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model","volume":"29","author":"Shukla","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-017-0334-z","article-title":"Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in transgenic adenocarcinoma of the mouse prostate (TRAMP)","volume":"24","author":"Silva","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2018.12.002_bb0285","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/cbin.10967","article-title":"Steroidal hormone and morphological responses in the prostate anterior lobe in different cancer grades after celecoxib and goniothalamin treatments in TRAMP mice","volume":"42","author":"Silva","year":"2018","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2018.12.002_bb0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1940-6207.CAPR-17-0389","article-title":"Inhibition of glycolysis in prostate cancer chemoprevention by phenethyl isothiocyanate","volume":"11","author":"Singh","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2018.12.002_bb0295","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/carcin\/bgy051","article-title":"Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism","volume":"39","author":"Singh","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2018.12.002_bb0300","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1158\/1078-0432.CCR-08-1309","article-title":"Silibinin inhibits established prostate tumor growth, progression, invasion and metastasis, and suppresses tumor angiogenesis and EMT in TRAMP mice","volume":"14","author":"Singh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0305","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2012-1030","article-title":"Aggressive prostate cancer is prevented in ERalphaKO mice and stimulated in ERbetaKO TRAMP mice","volume":"153","author":"Slusarz","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2018.12.002_bb0310","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and \u22122","volume":"271","author":"Smith","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.002_bb0315","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/onc.2016.232","article-title":"Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer","volume":"36","author":"Su","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.12.002_bb0320","doi-asserted-by":"crossref","first-page":"53751","DOI":"10.18632\/oncotarget.10733","article-title":"Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model","volume":"7","author":"Suman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2018.12.002_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/01926230390173842","article-title":"A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model","volume":"31","author":"Suttie","year":"2003","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0330","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/01926230590930272","article-title":"An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse","volume":"33","author":"Suttie","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0335","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/1940-6207.CAPR-15-0402","article-title":"Beta-carotene 9\u2032,10\u2032 oxygenase modulates the anticancer activity of dietary tomato or lycopene on prostate carcinogenesis in the TRAMP Model","volume":"10","author":"Tan","year":"2017","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2018.12.002_bb0340","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1354\/vp.42-3-306","article-title":"Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model","volume":"42","author":"Tani","year":"2005","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2014.12.023","article-title":"Chronic inflammatory mediators enhance prostate cancer development and progression","volume":"94","author":"Thapa","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0350","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00418-008-0440-9","article-title":"High level of endostatin in epididymal epithelium: protection against primary malignancies in this organ?","volume":"130","author":"Tilki","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0355","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0022-5347(05)65620-0","article-title":"Reactive stroma in prostate cancer progression","volume":"166","author":"Tuxhorn","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0360","first-page":"2912","article-title":"Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling","volume":"8","author":"Tuxhorn","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0365","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1158\/1940-6207.CAPR-11-0120","article-title":"Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer","volume":"4","author":"Uddin","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2018.12.002_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/895238","article-title":"Mouse models of prostate cancer","volume":"2011","author":"Valkenburg","year":"2011","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0375","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-04-0690","article-title":"Antioxidants block prostate cancer in lady transgenic mice","volume":"64","author":"Venkateswaran","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.002_bb0380","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","article-title":"Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2018.12.002_bb0385","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.111150898","article-title":"A role for estrogen receptor beta in the regulation of growth of the ventral prostate","volume":"98","author":"Weihua","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2018.12.002_bb0390","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/ERC-12-0285","article-title":"Current mouse and cell models in prostate cancer research","volume":"20","author":"Wu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0395","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1007\/s13277-015-4372-4","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2018.12.002_bb0400","article-title":"Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet","volume":"2015","author":"Xu","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2018.12.002_bb0405","first-page":"39","article-title":"Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate","volume":"10","author":"Yang","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2018.12.002_bb0410","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/acs.jproteome.8b00158","article-title":"Quantitative proteomics of TRAMP mice combined with bioinformatics analysis reveals that PDGF-B regulatory network plays a key role in prostate cancer progression","volume":"17","author":"Zhang","year":"2018","journal-title":"J. Proteome Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518307859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518307859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:17:58Z","timestamp":1758399478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518307859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":82,"alternative-id":["S0024320518307859"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}